FI861951A0 - 1,3-oxatianderivat. - Google Patents

1,3-oxatianderivat.

Info

Publication number
FI861951A0
FI861951A0 FI861951A FI861951A FI861951A0 FI 861951 A0 FI861951 A0 FI 861951A0 FI 861951 A FI861951 A FI 861951A FI 861951 A FI861951 A FI 861951A FI 861951 A0 FI861951 A0 FI 861951A0
Authority
FI
Finland
Prior art keywords
phenyl
alkyl
formula
so2r3
tetrazol
Prior art date
Application number
FI861951A
Other languages
English (en)
Other versions
FI84717C (fi
FI861951A (fi
FI84717B (fi
Inventor
Victor Giulio Matassa
Michael James Smithers
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI861951A0 publication Critical patent/FI861951A0/fi
Publication of FI861951A publication Critical patent/FI861951A/fi
Application granted granted Critical
Publication of FI84717B publication Critical patent/FI84717B/fi
Publication of FI84717C publication Critical patent/FI84717C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI861951A 1985-05-10 1986-05-09 Foerfarande foer framstaellning av ett terapeutiskt aktivt 1,3-oxatianderivat. FI84717C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8511894 1985-05-10
GB858511894A GB8511894D0 (en) 1985-05-10 1985-05-10 Phenol derivatives

Publications (4)

Publication Number Publication Date
FI861951A0 true FI861951A0 (fi) 1986-05-09
FI861951A FI861951A (fi) 1986-11-11
FI84717B FI84717B (fi) 1991-09-30
FI84717C FI84717C (fi) 1992-01-10

Family

ID=10578948

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861951A FI84717C (fi) 1985-05-10 1986-05-09 Foerfarande foer framstaellning av ett terapeutiskt aktivt 1,3-oxatianderivat.

Country Status (17)

Country Link
US (1) US4735963A (fi)
EP (1) EP0201350B1 (fi)
JP (1) JPS6212775A (fi)
AT (1) ATE58135T1 (fi)
AU (1) AU580162B2 (fi)
DE (1) DE3675431D1 (fi)
DK (1) DK164057C (fi)
ES (1) ES8802509A1 (fi)
FI (1) FI84717C (fi)
GB (1) GB8511894D0 (fi)
GR (1) GR861207B (fi)
HU (1) HU197737B (fi)
IL (1) IL78780A (fi)
NO (1) NO861868L (fi)
NZ (1) NZ216084A (fi)
PT (1) PT82550B (fi)
ZA (1) ZA863044B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
US4839384A (en) * 1988-10-07 1989-06-13 E. R. Squibb & Sons, Inc. Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
CN1034120C (zh) * 1988-10-21 1997-02-26 曾尼卡有限公司 制备二噁烷链烯酸衍生物的方法
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419883A1 (fr) 1978-03-13 1979-10-12 Maj Sarl Dispositif pour le conditionnement et la conservation sous vide en emballage plastique de produits sterilises, notamment du linge, dans un autoclave
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330120D0 (en) 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8417314D0 (en) 1984-07-06 1984-08-08 Ici Plc Carboxylic acid derivatives

Also Published As

Publication number Publication date
PT82550A (en) 1986-06-01
EP0201350A3 (en) 1987-10-28
DK215886D0 (da) 1986-05-09
AU5706886A (en) 1986-11-13
PT82550B (pt) 1988-08-17
FI84717C (fi) 1992-01-10
GR861207B (en) 1986-08-29
AU580162B2 (en) 1989-01-05
DK164057C (da) 1992-09-28
DK215886A (da) 1986-11-11
ES8802509A1 (es) 1988-07-16
IL78780A (en) 1990-02-09
FI861951A (fi) 1986-11-11
ATE58135T1 (de) 1990-11-15
EP0201350B1 (en) 1990-11-07
HU197737B (en) 1989-05-29
FI84717B (fi) 1991-09-30
HUT43578A (en) 1987-11-30
NO861868L (no) 1986-11-11
ES554830A0 (es) 1988-07-16
JPS6212775A (ja) 1987-01-21
ZA863044B (en) 1987-09-30
DE3675431D1 (de) 1990-12-13
NZ216084A (en) 1990-02-26
EP0201350A2 (en) 1986-11-12
US4735963A (en) 1988-04-05
DK164057B (da) 1992-05-04
GB8511894D0 (en) 1985-06-19

Similar Documents

Publication Publication Date Title
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
NO892952L (no) 4-oksokinolin-3-karboksylsyrederivater, fremgangsmaate tilfremstilling av og anvendelse av samme.
WO1999024022A3 (en) Isoquinoline derivatives for treating disorders associated with 5ht7 receptors
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
DE3675431D1 (de) 1,3-oxathianderivate.
HU895648D0 (en) Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds
EP0201349A3 (en) Tetrazole derivatives
ES8802507A1 (es) Procedimiento para preparar eteres 1,3-dioxano.
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
MX9205408A (es) Metodo para tratar hipertension.
DE69008130D1 (de) Glutarsäurederivate und ihre Herstellung.
DK210387D0 (da) Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC